FDA clears Pear Therapeutics' mobile app to help treat opioid abuse
The U.S. Food and Drug Administration on Monday cleared Pear Therapeutics' mobile application to help increase retention of patients undergoing outpatient treatment for opioid abuse.
No comments:
Post a Comment